News

Understand how diabetes may raise bone density over time, but fracture risk remains.

Discover how new research found that glipizide carries higher cardiovascular risk than DPP4 inhibitors in Type 2 diabetes treatment.

At least 60% of liver cancer diagnoses are linked to modifiable risk factors and could be prevented through global interventions

The study found that patients receiving the AR-PRISE intervention experienced significant improvements in symptom control, particularly over the longer term.

This study focused on eGDR, a widely accessible proxy for insulin sensitivity derived from waist circumference, hypertension status, and HbA1c levels.

Dialysis-requiring AKI after PCI remains rare but deadly, with high mortality and complication rates demanding vigilant care.

A nationwide Spanish study finds that nearly half of systemic sclerosis patients experience ARFID symptoms, often driven by GI discomfort and fear around eating.

A study shows that patients receiving stem cell transplants from HLA-mismatched unrelated donors can achieve strong survival outcomes with post-transplant cyclophosphamide (PTCy)-based graft-versus-host disease prevention.